Expert insights. Personalized for you.
The FDA has limited the use of COVID-19 antibody therapies developed by Eli Lilly and Regeneron, on the back of data suggesting they have are “highly unlikely” to be effective against the now-dominant Omicron variant. MORE
Clunky, costly, highly regulated health systems, often dominated by rent-seeking middlemen, are being shaken up by firms that target patients directly, meet them where they are—which is increasingly online—and give them more control over how to access care. MORE
An international team of scientists has determined the precise structural changes in the spike protein of the omicron variant. Their observations explain how the virus is able to evade antibodies against previous variants and still remain highly infectious. MORE
Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against the Omicron variant. MORE
“For too long, American workers have been left behind. Business leaders have a responsibility to their workers to understand the challenges and opportunities associated with building better jobs. MORE
The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientificâs Nantheia ATL5, a candidate for treating opioid use disorder. Clinical Development MORE
The trial, which will enroll nearly 1,500 people, could help determine whether a variant-specific shot is more effective than an additional booster of Pfizer's original vaccine MORE
A large study conducted in England found that, compared to the general population, people who had been hospitalized for COVID-19—and survived for at least one week after discharge—were more than twice as likely to die or be readmitted to the hospital in the next several months. MORE
The UCL study will evaluate the safety and effectiveness of MTL-CEBPA in combination with second line standard of care sorafenib versus the use of sorafenib in isolation MORE
Despite sliding stock prices, biotechs aren't "on sale," J&J CFO Joe Wolk said Tuesday. "It's really hard to say whether there's been a capitulation, or a recognition, that values have come down " MORE
Amsterdam, January 19, 2022: The covid-19 pandemic still poses enormous social challenges. People with cognitive impairments (problems with, for example, memory and concentration) and dementia are doubly affected by this pandemic. On the one hand, they have direct risk of severe Covid-19 symptoms. MORE
In a new study, Empa researcher Dominik Brunner, together with colleagues from Utrecht University and the Austrian Central Institute for Meteorology and Geophysics, is investigating how much plastic is trickling down on us from the atmosphere. MORE
The biotech said it plans to soon submit the drug, which it acquired for cheap from Gilead three years ago, to the Food and Drug Administration for approval MORE
The biotech raised the Series B round during "probably one of the worst biotech markets" emerging drugmakers have faced in some time, a Metagenomi executive told BioPharma Dive MORE
Link to full release: Credit: Luther Davis/Alexey Merz/University of Washington Link to full release: [link] FROM: James Urton University of Washington 206-543-2580 jurton@uw.edu (NOTE: researcher contact information at end) For Immediate Release Jan. MORE
Am expert from the CRO discusses unique challenges associated with running clinical trials that stretch across national boarders and how to conquer them. Clinical Development MORE
DURHAM, N.C. — The Albemarle-Pamlico Peninsula covers more than 2,000 square miles on the North Carolina coastal plain, a vast expanse of forested swamps and tea-colored creeks. MORE
83 
This chart shows the pharmaceutical companies with the most patents in Australia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Australia? MORE
Diatoms, single-celled algae typically enshrined in a siliceous cell wall, generally act as opportunistic organisms, reproducing uncontrollably in the presence of favorable conditions, but are also able to make altruistic decisions acting for the good of the community. MORE
82 
For governments and clean energy advocates looking to encourage people to use e-bikes for transportation, a new online tool from Portland State University researchers offers an overview of the existing incentive programs in the United States and Canada. MORE
It’s advice Logan Roy, the fictional patriarch from the TV program Succession, would not want to hear but must heed: family businesses must prepare the next generation or risk watching their businesses crumble. MORE
83 Highly radioactive fuel debris remains in the reactors. Credit: Satoshi Utsunomiya Highly radioactive fuel debris remains in the reactors. Decommissioning and clean-up are ongoing at the Fukushima Daiichi Nuclear Power Plant (FDNPP); however, many difficult problems remain unaddressed. MORE
Biotech EdiGene has announced an R&D collaboration with Haihe Laboratory of Cell Ecosystem to develop hematopoietic stem cell regenerative therapies and platform technology. Bio Developments MORE
80 Raffaella De Vita, professor and associate department head in the Department of Biomedical Engineering and Mechanics in the College of Engineering, has been awarded a National Science Foundation (NSF) award to study the biomechanics of gender affirming surgery. MORE
The construction of Yposkesiâs second facility is on track, the French CDMO has confirmed. Upstream Processing MORE
78 
GlaxoSmithKline plc (GSK) says the US Food and Drug Administration (FDA) has approved its anti-IL-5 biologic Nucala (mepolizumab) in a 40 mg pre-filled syringe for children aged 6 to 11 years old with severe eosinophilic asthma (SEA). Markets & Regulations MORE
The area of digital therapeutics is growing rapidly, and in this piece Ben Hargreaves examines why this is the case, how broadly these therapies can be applied and why investment in the area is mounting. MORE
PULLMAN, Wash. – New research, led by Washington State University scientists, into how viral proteins interact and can be disabled holds promise to help plants defend themselves against viruses—and ultimately prevent crop losses. MORE
Music is often considered a universal language, as it crosses language barriers and connects people all over the world with ease. In fact, songs are popularly used in foreign language classrooms as a means to expose students to authentic content in the language being taught. MORE
The UK company behind a sleep mask that aims to treat sight-robbing complications of diabetes has secured $10 million in funding that will be used to run trials of the medical device. MORE
Oskar Möbert, Vice President OpenData Europe at Veeva Systems, tells us how they are reimagining customer reference data to boost pharma rep productivity, enable more personalised engagement, and increase patient reach. MORE
Bio Pharma Dive
JANUARY 25, 2022
The biotech raised the Series B round during "probably one of the worst biotech markets" emerging drugmakers have faced in some time, a Metagenomi executive told BioPharma Dive
World of DTC Marketing
JANUARY 25, 2022
Clunky, costly, highly regulated health systems, often dominated by rent-seeking middlemen, are being shaken up by firms that target patients directly, meet them where they are—which is increasingly online—and give them more control over how to access care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 25, 2022
Despite sliding stock prices, biotechs aren't "on sale," J&J CFO Joe Wolk said Tuesday. "It's really hard to say whether there's been a capitulation, or a recognition, that values have come down "
Scienmag
JANUARY 25, 2022
In a new study, Empa researcher Dominik Brunner, together with colleagues from Utrecht University and the Austrian Central Institute for Meteorology and Geophysics, is investigating how much plastic is trickling down on us from the atmosphere.
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Bio Pharma Dive
JANUARY 25, 2022
The trial, which will enroll nearly 1,500 people, could help determine whether a variant-specific shot is more effective than an additional booster of Pfizer's original vaccine
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
|
Bio Pharma Dive
JANUARY 25, 2022
The biotech said it plans to soon submit the drug, which it acquired for cheap from Gilead three years ago, to the Food and Drug Administration for approval
Scienmag
JANUARY 25, 2022
It’s advice Logan Roy, the fictional patriarch from the TV program Succession, would not want to hear but must heed: family businesses must prepare the next generation or risk watching their businesses crumble.
Pharma Phorum
JANUARY 25, 2022
The area of digital therapeutics is growing rapidly, and in this piece Ben Hargreaves examines why this is the case, how broadly these therapies can be applied and why investment in the area is mounting.
Scienmag
JANUARY 25, 2022
For governments and clean energy advocates looking to encourage people to use e-bikes for transportation, a new online tool from Portland State University researchers offers an overview of the existing incentive programs in the United States and Canada.
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Pharma Phorum
JANUARY 25, 2022
The UK company behind a sleep mask that aims to treat sight-robbing complications of diabetes has secured $10 million in funding that will be used to run trials of the medical device.
Scienmag
JANUARY 25, 2022
PULLMAN, Wash. – New research, led by Washington State University scientists, into how viral proteins interact and can be disabled holds promise to help plants defend themselves against viruses—and ultimately prevent crop losses.
Pharma Phorum
JANUARY 25, 2022
Oskar Möbert, Vice President OpenData Europe at Veeva Systems, tells us how they are reimagining customer reference data to boost pharma rep productivity, enable more personalised engagement, and increase patient reach.
Scienmag
JANUARY 25, 2022
Amsterdam, January 19, 2022: The covid-19 pandemic still poses enormous social challenges. People with cognitive impairments (problems with, for example, memory and concentration) and dementia are doubly affected by this pandemic. On the one hand, they have direct risk of severe Covid-19 symptoms.
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
Outsourcing Pharma
JANUARY 25, 2022
The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientificâs Nantheia ATL5, a candidate for treating opioid use disorder. Clinical Development
Scienmag
JANUARY 25, 2022
DURHAM, N.C. — The Albemarle-Pamlico Peninsula covers more than 2,000 square miles on the North Carolina coastal plain, a vast expanse of forested swamps and tea-colored creeks.
Outsourcing Pharma
JANUARY 25, 2022
Am expert from the CRO discusses unique challenges associated with running clinical trials that stretch across national boarders and how to conquer them. Clinical Development
Scienmag
JANUARY 25, 2022
A large study conducted in England found that, compared to the general population, people who had been hospitalized for COVID-19—and survived for at least one week after discharge—were more than twice as likely to die or be readmitted to the hospital in the next several months.
Drug Patent Watch
JANUARY 25, 2022
This chart shows the pharmaceutical companies with the most patents in Australia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Australia?
Scienmag
JANUARY 25, 2022
Music is often considered a universal language, as it crosses language barriers and connects people all over the world with ease. In fact, songs are popularly used in foreign language classrooms as a means to expose students to authentic content in the language being taught.
Pharma Phorum
JANUARY 25, 2022
The FDA has limited the use of COVID-19 antibody therapies developed by Eli Lilly and Regeneron, on the back of data suggesting they have are “highly unlikely” to be effective against the now-dominant Omicron variant.
Scienmag
JANUARY 25, 2022
Raffaella De Vita, professor and associate department head in the Department of Biomedical Engineering and Mechanics in the College of Engineering, has been awarded a National Science Foundation (NSF) award to study the biomechanics of gender affirming surgery.
Pharma Phorum
JANUARY 25, 2022
Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against the Omicron variant.
Scienmag
JANUARY 25, 2022
An international team of scientists has determined the precise structural changes in the spike protein of the omicron variant. Their observations explain how the virus is able to evade antibodies against previous variants and still remain highly infectious.
BioPharma Reporter
JANUARY 25, 2022
GlaxoSmithKline plc (GSK) says the US Food and Drug Administration (FDA) has approved its anti-IL-5 biologic Nucala (mepolizumab) in a 40 mg pre-filled syringe for children aged 6 to 11 years old with severe eosinophilic asthma (SEA). Markets & Regulations
Scienmag
JANUARY 25, 2022
Diatoms, single-celled algae typically enshrined in a siliceous cell wall, generally act as opportunistic organisms, reproducing uncontrollably in the presence of favorable conditions, but are also able to make altruistic decisions acting for the good of the community.
BioPharma Reporter
JANUARY 25, 2022
Biotech EdiGene has announced an R&D collaboration with Haihe Laboratory of Cell Ecosystem to develop hematopoietic stem cell regenerative therapies and platform technology. Bio Developments
Scienmag
JANUARY 25, 2022
Highly radioactive fuel debris remains in the reactors. Credit: Satoshi Utsunomiya Highly radioactive fuel debris remains in the reactors. Decommissioning and clean-up are ongoing at the Fukushima Daiichi Nuclear Power Plant (FDNPP); however, many difficult problems remain unaddressed.
Pharma Times
JANUARY 25, 2022
The UCL study will evaluate the safety and effectiveness of MTL-CEBPA in combination with second line standard of care sorafenib versus the use of sorafenib in isolation
Scienmag
JANUARY 25, 2022
“For too long, American workers have been left behind. Business leaders have a responsibility to their workers to understand the challenges and opportunities associated with building better jobs.
BioPharma Reporter
JANUARY 25, 2022
The construction of Yposkesiâs second facility is on track, the French CDMO has confirmed. Upstream Processing
Let's personalize your content